Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Biohaven Advances Toward Potential First FDA-Approved Therapy For Spinocerebellar Ataxia, FDA Drops Advisory Meeting

Biohaven Ltd. (NYSE:BHVN) stock is trading higher on Friday following an update with respect to its New Drug Application for troriluzole for adult patients with Spinocerebellar Ataxia (SCA).

Benzinga

Worried About a Market Crash? Here Are 3 Stocks That ‘Big Short’ Star Michael Burry Loves Here.

Here are three top stocks that the ‘Big Short’ star Michael Burry owns in Q2 of 2025. Are UNH, REGN, and LULU undervalued right now?

Barchart

Ionis Pharma Wins FDA Nod For First RNA-Targeted Therapy For Rare Genetic Swelling Disorder

On Thursday, the U.S. Food and Drug Administration (FDA) approved Ionis Pharmaceuticals, Inc.’s (NASDAQ:IONS) Dawnzera (donidalorsen) for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years

Achieve Life Sciences Inc. (NASDAQ:ACHV) is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a potential first new smoking cessation therapy in nearly two decades, positioning the company for a high-stakes commercial launch in 2026.

Benzinga

Why So Many Nutrition Panels Have Been Quietly Altered

If you have a keen eye, you may have noticed that the Nutrition Facts panel on your favorite packaged foods looks different from what it did a few years ago. These changes are not your imagination. Food manufacturers have been quietly altering their nutrition labels for a variety of reasons,…

Grocery Coupon Guide

Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy

As biotechnology companies increasingly seek innovative approaches to enhance cancer treatment, strategic acquisitions are becoming a key pathway for expanding capabilities and integrating advanced therapeutic platforms. Kite Pharma, a Gilead Sciences Inc. company (NASDAQ:GILD) on Thursday agreed to acquire Interius BioTherapeutics, a privately held biotechnology company developing in vivo CAR…

Benzinga

Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Month

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Walmart recalls frozen shrimp in the US over potential radioactive contamination

One food safety expert says the risk is low from the recalled shrimp, which was sold in 13 US states.

Euronews

Lung Disease-Focused Insmed 'Must-Own' Name For Investors

William Blair initiated coverage on Insmed Incorporated (NASDAQ:INSM), citing that the clinical and commercial execution of its drugs can significantly increase Insmed's valuation.

Benzinga

'Radioactive Shrimp': Do They Glow in the Dark and Why Walmart Is Pulling Them

So-called 'radioactive shrimp' have sparked panic online, with Walmart pulling the product after safety concerns. But do they really glow in the dark and what's behind the scare?

International Business Times UK

FDA Lifts Rocket Pharmaceuticals Study Hold For Rare Disease Gene Therapy

Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) stock is trading higher on Wednesday after the U.S. Food and Drug Administration (FDA) lifted the clinical hold on its pivotal Phase 2 trial of RP-A501 for Danon disease.

Benzinga

Walmart shrimp laced with radioactive material, FDA warns public as it can damage DNA

But Americans' reactions have so far been unexpectedly lighthearted.

We Got This Covered

Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) rose sharply in pre-market trading after the company disclosed that the FDA has lifted the clinical hold on the pivotal Phase 2 trial of RP-A501 for the treatment of Danon disease.

Benzinga

Two years on from Australia’s bold psychedelic experiment, here are our concerns

A small Australian trial that used psychedelic-assisted therapy to improve the mental health and wellbeing of terminally ill patients is in the news today.

The Conversation

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times UK

Can Radioactive Shrimp Kill You? Walmart Seafood Poses Danger As FDA Issues 'Do Not Sell' Warning

FDA warns against Walmart's Great Value shrimp over possible cesium-137 contamination. Seafood recall alert with shrimp lot codes and safety details.

The Independent UK

Walmart recalls Great Value frozen shrimp products

IN FULL

The Independent UK

FDA recalls five types of cheese over contamination concerns

IN FULL

LiveScience

FDA recalls more bagged, frozen shrimp over possible radioactive cesium contamination

The FDA is warning consumers not to eat certain frozen shrimp products sold at Walmart after other products from the same company tested positive for a radioactive substance.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Walmart recalls shrimp over possible radioactive contamination

FDA announced that certain Great Value raw frozen shrimp sold at Walmart could be potentially contaminated with Cesium-137, a radioactive isotope

The Independent UK

Thousands of pounds of cheese recalled over possible Listeria contamination

The source was determined to be ‘from environmental contamination that migrated to food-contact areas of the production process’

Benzinga

FDA Extends Decision Date On Regenxbio's Gene Therapy Into Next Year

The U.S. Food and Drug Administration (FDA) on Monday extended its review timeline for REGENXBIO Inc.’s (NASDAQ:RGNX) Biologics License Application (BLA) for clemidsogene lanparvovec (RGX-121) for Mucopolysaccharidosis II (MPS II), also known as Hunter syndrome.

Benzinga

PTC Therapeutics Faces FDA Rejection On Rare Disease Treatment Over Efficacy Concerns

The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) on Tuesday related to PTC Therapeutics, Inc.‘s (NASDAQ:PTCT) New Drug Application (NDA) for vatiquinone for Friedreich’s ataxia.

Grocery Coupon Guide

10 Label Terms That Mean Nothing Legally

The front of a food package is a battlefield for your attention, and marketers use a powerful arsenal of unregulated buzzwords to win your trust. These terms are carefully chosen to make a product seem healthier, higher-quality, or more wholesome than it is. However, because these words have no official,…

Medical Daily

FDA Cracks Down on Whipped Sunscreens, Citing Lack of Approval and Safety Concerns

FDA warns consumers to avoid whipped, mousse, and foam sunscreens due to safety and lack of approval.

Benzinga

Fabrinet, Adecoagro And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures were mixed this morning, with the SP 500 futures falling around 0.1% on Monday.

1 … 20 21 22 23

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.